Thus, the SARS-CoV-2 infection causes altered insulin secretion by impaired ß-pancreatic cell function or inflammation-induced insulin resistance, with the triggering of pleiotropic effects that affect glucose metabolism, exacerbating a pre-existing DM or triggering de novo DM [15]. The gene discussed is INS; the disease is diabetes mellitus.